Kraig Biocraft Laboratories, Inc. (KBLB) — 10-Q Filings

10-Q Filings (6)

• Kraig Biocraft's Losses Widen Amidst Zero Revenue, Equity Infusion Boosts Cash — Nov 12, 2025 Risk: high
  Kraig Biocraft Laboratories, Inc. reported a net loss of $2,835,732 for the nine months ended September 30, 2025, an increase from the $2,547,264 net loss in th
• Kraig Biocraft Narrows Q2 Loss Amidst Zero Revenue, Equity Infusion — Aug 14, 2025 Risk: high
  Kraig Biocraft Laboratories, Inc. reported no revenue for the three and six months ended June 30, 2025, consistent with the prior year. The company's net loss s
• Kraig Biocraft Labs Files Q1 2025 10-Q — May 15, 2025 Risk: medium
  Kraig Biocraft Laboratories, Inc. filed its 10-Q for the period ending March 31, 2025. The company, based in Ann Arbor, MI, is involved in the production of pla
• Kraig Biocraft Labs Files Q3 2024 10-Q — Nov 13, 2024 Risk: medium
  Kraig Biocraft Laboratories, Inc. filed its 10-Q for the period ending September 30, 2024. The filing details the company's financial position and operational a
• Kraig Biocraft Labs Files Q2 2024 10-Q — Aug 14, 2024 Risk: medium
  Kraig Biocraft Laboratories, Inc. filed its 10-Q for the period ending June 30, 2024. The filing details the company's financial position and operational activi
• Kraig Biocraft Laboratories, Inc. Files 10-Q for Period Ending March 31, 2024 — May 14, 2024 Risk: low
  Kraig Biocraft Laboratories, Inc (KBLB) filed a Quarterly Report (10-Q) with the SEC on May 14, 2024. Kraig Biocraft Laboratories, Inc. filed a 10-Q report on M

Popular Companies

AAPL · TSLA · MSFT · AMZN · GOOGL · META · NVDA · JPM · BRK-B · V · JNJ · UNH · XOM · WMT · MA · PG · HD · DIS · BAC · NFLX